Iwase T, Sridhar N, Kai M, Dong W, et al. Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study. Breast Cancer Res Treat 2025 Aug 2. doi: 10.1007/s10549-025-07795.
PMID: 40753318